Seebri Breezhaler
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Seebri Breezhaler, covering 2018-09-14 to 2026-01-26. Get the full timeline:
Most recent: EMA Authorised: Seebri Breezhaler (glycopyrronium bromide) — Novartis Europharm Limited